Prognostic Impact of Lymphoid Enhancer Factor 1 Expression and Serum Galectin.3 in Egyptian AML Patients von El-Ghonemy, M., Ibrahim, L., El-Beshbishi, Wafaa, Akl, Tamer, Atwa, Sara, El Zaafarany, M., Aref, Salah, ElBaiomy, M. A., El-Ashwah, Shaimaa

Volltext

Clinical Impact of Breast Cancer Stem Cells in Metastatic Breast Cancer Patients von El Zaafarany, M., Elsayed, Ahmed Ali, Atwan, Nadia, Akl, Tamer, ElBaiomy, M. A., Shamaa, S.

Volltext

Osteopontin level and promoter polymorphism is associated with aggressiveness in breast cancer von Elbaiomy, M.A., El-Ghonemy, M.S., Elhelaly, R., Elzehery, R.

Volltext

Osteopontin level and promoter polymorphism in patients with metastatic breast cancer von Elbaiomy, M A, Akl, T, Elhelaly, R, El-Beshbishi, W, El Ghonemy, M S, Elzehery, R

Volltext

Molecular Mechanisms Mediating Ceftazidime/Avibactam Resistance Amongst Carbapenem-Resistant Klebsiella pneumoniae Isolates from Cancer Patients von Kady, Rania Abd El-Hamid El, Elbaiomy, Mohamed Ali, Elnagar, Rasha Mokhtar

Volltext

PB2419: THE OUTCOME OF VIRAL HEPATITIS‐C INFECTION ON HEMATOLOGICAL MALIGNANCIES AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION IN EGYPT von Elashwah, Salma, Elbaiomy, MA, Samra, Mohamed, El‐Ashwah, Shaimaa, Abdelfattah, Raafat, Fathy, Gamal, Shamaa, Sameh

Volltext

ABCL-310 Triple Metachronous Malignancies in Primary Diagnosed Diffuse Large B-Cell Lymphoma Patient: A Case Report von Elashwah, Salma, AboElfarh, Hadeer Elsaeed, Atwa, Sara, Attia, Samar, ElBaiomy, M.A., Shamaa, Sameh

Volltext

43POsteopontin level and promoter polymorphism is associated with aggressiveness in breast cancer von Elbaiomy, M A, El-Ghonemy, M S, Elhelaly, R, Elzehery, R

Volltext

ABCL-175 Bilharzial Colitis Post-Autologous Stem Cell Transplantation in Non-Hodgkin Lymphoma Patient: A Case Report von El-Ashwah, Shaimaa, Elbayoumi, Noreen, Denewer, May, ELboghdady, Mohamed, Azmy, Emad, Mabed, Mohamed, Saleh, Gehad, ElBaiomy, M.A., Elzaafarany, Maha, Ebrahim, Mohamed A., Salah-Eldin, Manal A., ElKhodary, Tawfik, Ghazy, Hayam, Shamaa, Sameh

Volltext

Osteopontin Level and Promoter Polymorphism in Patients with Metastatic Breast Cancer von Elbaiomy, M A, Akl, T, Elhelaly, R, El-Beshbishi, W, El Ghonemy, M S, Elzehery, R

Volltext

Thrombophilic Risk of Factor V Leiden, Prothrombin G20210A, MTHFR, and Calreticulin Mutations in Essential Thrombocythemia Egyptian Patients von Denewer, May, El-Ashwah, Shaimaa, Fahmi, Maryan Waheeb, El Sharawy, Solafa, El-Ghonemy, M., ElBaiomy, M. A.

Volltext

Theoretical modeling of laser light generation and color image formation: FA1:Tl+ and FA2:Ga+ color centers at the low coordination (100) and (110) surfaces of AgCl and AgBr von Shalabi, A.S., Kamel, M.A., Elbaiomy, M.A., Halim, W.S. Abdel

Volltext

Theoretical modeling of laser light generation and color image formation : FA1:T1+ and FA2:Ga+ color centers at the low coordination (100) and (110) surfaces of AgCl and AgBr von SHALABI, A. S, KAMEL, M. A, ELBAIOMY, M. A, ABDEL HALIM, W. S

Volltext

P-8 Circulating tumor DNA could have impact on risk assessment and personalizing adjuvant therapy in localized colon cancer von Elbaiomy, M., Sabry, M.

Volltext

P-42 How to improve outcome in high-risk stage III colon cancer with dMMR gene von Abdelsalam, Y., Elbaiomy, M.

Volltext

P-184 Prognostic value of mTOR expression and mismatch repair gene profile in advanced gastric and gastro-oesophageal cancer von Elbaiomy, M., Elsayed, A.

Volltext

P-218 Prognostic value of mTOR expression and mismatch repair gene profile in advanced gastric and gastro-oesophygeal cancer von Elbaiomy, M., Elsayed, A.

Volltext

P-182 Anti-EGFR antibodies may get benefit as first-line treatment in metastatic right-sided colon cancer von Elbaiomy, M., Elsayed, A., Akl, T.

Volltext

Prognostic Value of TLE1 Gene Expression in Patients with T-cell Acute Lymphoblastic Leukemia von Aref, Salah, El-Ghonemy, Mohamed Sabry, Atia, Doaa Mohamed, Elbaiomy, Mohamed M, Abdelsalam, Sherehan Adel, Tawfik, Aya, EL-Sebaie, Ahmed

Volltext

Repurposing metformin as anticancer drug: Randomized controlled trial in advanced prostate cancer (MANSMED) von Alghandour, Reham, Ebrahim, Mohamed A., Elshal, Ahmed M., Ghobrial, Fady, Elzaafarany, Maha, ELbaiomy, Mohamed A.

Volltext